Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001104659-21-143846
Filing Date
2021-11-26
Accepted
2021-11-26 11:43:28
Documents
1
Effectiveness Date
2021-11-26

Document Format Files

Seq Description Document Type Size
1 25 tm2133952d1_25.htm 25 10062
  Complete submission text file 0001104659-21-143846.txt   11130
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25 | Act: 34 | File No.: 001-39202 | Film No.: 211450452
SIC: 2834 Pharmaceutical Preparations